| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2893.2001.00311.X |
| P698 | PubMed publication ID | 11555194 |
| P2093 | author name string | K Suzuki | |
| T Abe | |||
| M Mori | |||
| K Sato | |||
| T Otsuka | |||
| Y Hashimoto | |||
| S Sato | |||
| H Takagi | |||
| J Takezawa | |||
| T Matsumoto | |||
| T Nagamine | |||
| H Takayama | |||
| S Kakizaki | |||
| A Kojima | |||
| P2860 | cites work | Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography | Q27734359 |
| Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group | Q27861083 | ||
| Inhibition of HIV-1 infection by zinc group metal compounds | Q28374014 | ||
| Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis. | Q30579693 | ||
| Zinc and immunoresistance to infection in aging: new biological tools | Q33934266 | ||
| Zinc supplementation and stunted infants in Ethiopia: a randomised controlled trial | Q34509540 | ||
| Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment. | Q42991587 | ||
| Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C. | Q42996578 | ||
| N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. | Q54234862 | ||
| Effects of zinc L-carnosine on gastric mucosal and cell damage caused by ethanol in rats. Correlation with endogenous prostaglandin E2. | Q54324829 | ||
| P433 | issue | 5 | |
| P921 | main subject | chronic hepatitis | Q62019625 |
| P304 | page(s) | 367-371 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. | |
| P478 | volume | 8 |
| Q89977470 | A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders |
| Q35585469 | Antioxidants as therapeutic agents for liver disease |
| Q49232850 | Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease |
| Q37278198 | Blood cell, liver function, and response changes by PEG-interferon-alpha2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C |
| Q36190363 | Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. |
| Q38025376 | Can zinc enhance response interferon therapy for patients with HCV-related liver disease? |
| Q79264261 | Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease |
| Q42217842 | Clinicopathological and prognostic significance of preoperative serum zinc status in patients with hepatocellular carcinoma after initial hepatectomy |
| Q34279897 | Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami |
| Q43040192 | Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease |
| Q58617707 | Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection |
| Q42236944 | Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. |
| Q43048096 | Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment |
| Q37691145 | Impact of the discovery of human zinc deficiency on health |
| Q50557331 | Interferon-alpha-2a and zinc combination therapy in children with chronic hepatitis B infection. |
| Q37760464 | Necrolytic acral erythema as a cutaneous marker of hepatitis C: report of two cases and review. |
| Q35879726 | Oxidative stress in viral hepatitis and AIDS. |
| Q46840361 | Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice |
| Q33788596 | Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2. |
| Q41400511 | Serum Zinc and Haptoglobin in Noncirrhotic Azeri Patients with Chronic Active Hepatitis C: a Case-Control Study |
| Q92855971 | The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus |
| Q91882018 | The Role of Zinc in Antiviral Immunity |
| Q47295182 | The antiviral role of zinc and metallothioneins in hepatitis C infection. |
| Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
| Q36792806 | The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice |
| Q34013192 | Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial |
| Q50573993 | Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. |
| Q80291540 | Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72 |
| Q37981597 | Zinc and liver disease |
| Q33852159 | Zinc in Infection and Inflammation |
| Q40221698 | Zinc is a negative regulator of hepatitis C virus RNA replication. |
| Q37407491 | Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis |
| Q40641856 | Zinc-Responsive Necrolytic Acral Erythema in a Patient With Psoriasis: A Rare Case |
Search more.